Plandai Biotechnology’s Phytofare Gaining Traction in International Markets

2018 Focus for U.S. Expansion After Initial Success with NutriBullet

LONDON, UNITED KINGDOM, May 09, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available extracts, is pleased to provide an update on its successful roll-out of its Phytofare® supplement.

Phytofare is now utilized as a supplement in over 40 products worldwide. More than 30 customers include Phytofare® as a key ingredient in food and beverage, wellness, anti-aging, cosmaceutical or nutraceutical.

Plandaí Biotech’s Phytofare®, is the only clinically proven green tea extract shown to be bioavailable. Generic green tea extracts are thought to have bioavailability of between 1-10% whereas Phytofare® has shown in a human bioavailability study to have a bioavailability of 10 times that of generic green tea extract. Phytofare® green tea leaves are grown on Plandaí’s estate in South Africa, providing full traceability, consistency and assurance.

Phytofare® is suitable for the sports nutrition, beauty, health and wellness, and anti-aging categories in the following formats:

• Capsules

• Tablets

• Powder blends

• Gels

• Foods 

After having built a solid customer base in Europe, Plandai is now looking to capitalize in the U.S. market. The focus for remainder of 2018 and 2019, is to expand Phytofare’s® visibility, awareness and sales in the U.S.

Phytofare’s® initial success in the U.S. has been in the Nutribullet Fat burning blend. NutriBullet SuperFoods reformulated its product, SuperFood Fat Burning Boost to include Plandaí's Phytofare Catechin Complex. More than 40 million NutriBullet units have been sold worldwide.

SuperFood Fat Burning Boost

Get over twice the amount of your favorite fat-burning superfoods in this 300-gram tub. Its resealable lid keeps contents fresher, longer, while the single-serving scoop included inside dishes out the perfect amount of thermogenic, metabolism- boosting* compounds! Learn more about the ingredients below. Each tub contains 60 servings.

About Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. (OTC Markets: PLPL) develops highly bioavailable, phytonutrient rich extracts which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology, through its South African subsidiaries, controls every aspect of production, from growing specific raw materials such as green tea on its farms to producing its proprietary Phytofare extract, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. The manufacturing facility has also been engineered for citrus fruits and the recovery of limonoids. Targeted industries for the Company's products include animal husbandry, dietary supplements, and diabetes. Plandai Biotechnology is headquartered in London, United Kingdom. For more information, please visit:  

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


Contact Data